APA (7th ed.) Citation

Gold, R., Piani-Meier, D., Kappos, L., Bar-Or, A., Vermersch, P., Giovannoni, G., . . . Cree, B. A. C. (2022). Siponimod vs placebo in active secondary progressive multiple sclerosis: A post hoc analysis from the phase 3 EXPAND study. Journal of neurology, 269(9), 5093-5104. https://doi.org/10.1007/s00415-022-11166-z

Chicago Style (17th ed.) Citation

Gold, Ralf, et al. "Siponimod Vs Placebo in Active Secondary Progressive Multiple Sclerosis: A Post Hoc Analysis from the Phase 3 EXPAND Study." Journal of Neurology 269, no. 9 (2022): 5093-5104. https://doi.org/10.1007/s00415-022-11166-z.

MLA (9th ed.) Citation

Gold, Ralf, et al. "Siponimod Vs Placebo in Active Secondary Progressive Multiple Sclerosis: A Post Hoc Analysis from the Phase 3 EXPAND Study." Journal of Neurology, vol. 269, no. 9, 2022, pp. 5093-5104, https://doi.org/10.1007/s00415-022-11166-z.